PCRX FY 2012 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$982M

FY 2012 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$39M+149.1% YoY

Gross Profit

$7M17.8% margin

Operating Income

-$49M-126.1% margin

Net Income

-$52M-133.8% margin

EPS (Diluted)

$-1.72

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$88M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$112M

Total Liabilities

$46M

Stockholders' Equity

$66M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$16M	+149.1%
Gross Profit	$7M	-$1M	+761.4%
Operating Income	-$49M	-$39M	-26.1%
Net Income	-$52M	-$43M	-20.7%